Pharmaceutical formulation comprising microcapsules of statins suspended in alkyl esters of polyunsaturated fatty acids (PUFA)

Details for Australian Patent Application No. 2005298587 (hide)

Owner Defiante Farmaceutica S.A. GP Pharm S.A.

Inventors Carminati, Paolo; Parente, Antonio

Agent Davies Collison Cave

Pub. Number AU-B-2005298587

PCT Pub. Number WO2006/045865

Priority P200402492 19.10.04 ES

Filing date 13 October 2005

Wipo publication date 4 May 2006

Acceptance publication date 5 August 2010

International Classifications

A61K 9/10 (2006.01) Medicinal preparations characterised by special physical form - Dispersions

A61K 9/50 (2006.01) Medicinal preparations characterised by special physical form - Microcapsules

A61K 31/20 (2006.01)

A61P 3/06 (2006.01) Drugs for disorders of the metabolism

Event Publications

10 May 2007 PCT application entered the National Phase

  PCT publication WO2006/045865 Priority application(s): WO2006/045865

19 July 2007 Amendment Made

  The nature of the amendment is: Amend the invention title to read Pharmaceutical formulation comprising microcapsules of statins suspended in alkyl esters of polyunsaturated fatty acids (PUFA)

6 August 2009 Alteration of Name

  The name of the applicant has been altered to Defiante Farmaceutica S.A.; GP Pharm S.A. Amendments

5 August 2010 Application Accepted

  Published as AU-B-2005298587

2 December 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005298593-Glass-darkening system which is suitable for windows and similar

2005298586-Improved liquefier